$15 Million Award to Go Toward Exploring New Treatments for Autism, Other Brain Disorders

June 18, 2014

CaptionDURHAM, N.C. -- Duke Medicine has been awarded $15 million to support an innovative research program that explores the use of umbilical cord blood cells to treat autism, stroke, cerebral palsy and related brain disorders.

The award from The Marcus Foundation, an Atlanta-based philanthropic organization, will fund the first two years of a planned five-year, $41 million project by Joanne Kurtzberg, M.D., chief scientific and medical officer of Duke’s Robertson Cell and Translational Therapy Program, and Geraldine Dawson, Ph.D., director of the Duke Center for Autism Diagnosis and Treatment.

Read the full news release.